03 April 2017

Make a difference in the lives of Australian men affected by prostate cancer: PCFA opens its 2017 funding round

Monday 3 April 2017: Prostate Cancer Foundation of Australia (PCFA) opens its annual funding round today, with the aim of supporting groundbreaking prostate cancer research. Basic and clinical sciences researchers are eligible across a range of categories from young investigators to clinically qualified professionals.

Researchers around the country are invited to submit applications across the following categories:

  • Clinician Scientist Award – supports outstanding, clinically qualified professionals who have gained a PhD in health research to combine their clinical career with a research career and establish themselves as independent researchers in the field of prostate cancer. Up to $450K over a period of 3 years.
  • Young Investigator Award – provides catalytic funding for early, post-doctoral researchers to help further their research and attract ongoing funding. Up to 150K over a period of 18 months.
  • New Concept Grant – supports first-in-field, high risk approaches that have the potential to generate new research directions in prostate cancer. Up to 100K over a period of 12 months.

"High quality research can potentially lead to the discovery of new ideas as well as the advancement of knowledge. It is our mission to support the best scientific talent in prostate cancer research nationally and are pleased to announce the opening of the funding round," Associate Professor Anthony Lowe, CEO of PCFA said.

"With over 3,300 men dying of prostate cancer each year, I look forward to seeing breaking new research proposals that will significantly reduce the impact of prostate cancer on Australian men, their partners and families, recognising the diversity of the Australian community," he said.

Full details about the PCFA's Research Program, grant categories and application details can be found at www.pcfa.org.au/research